Rockefeller Capital Management
KZIA

Rockefeller Capital Management’s Kazia Therapeutics KZIA Stock Holding History

Rockefeller Capital Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.5K Buy
12,700
+2,000
+19% +$13.9K ﹤0.01% 2909
2025
Q4 		$73.7K Hold
10,700
– – ﹤0.01% 2877
2025
Q3 		$77.1K Buy
+10,700
New +$88.8K ﹤0.01% 2707

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Rockefeller Capital Management's KZIA Position: Q1 2026 in Review

Rockefeller Capital Management increased its Kazia Therapeutics (KZIA) stake by 19% in Q1 2026, buying an estimated $13.9K and bringing the position to 12,700 shares worth $94.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2909.

Rockefeller Capital Management first reported a position in KZIA in Q3 2025 and has held it in 3 quarters since. 23 funds tracked by Wall St. Rank hold KZIA as of Q1 2026.

  • Rockefeller Capital Management held 12,700 shares of Kazia Therapeutics worth $94.5K as of Q1 2026.
  • Rockefeller Capital Management bought 2,000 Kazia Therapeutics shares in Q1 2026, an estimated $13.9K.
  • Kazia Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2909 holding.
  • Rockefeller Capital Management first reported a position in Kazia Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 23 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.